Recent research studies have shown the aberrant expression of HOXB-AS3 in tumor tissues and cancer cell lines, and significant correlations have been established between the dysregulation of HOXB-AS3 and specific clinicopathological characteristics, along with the prognosis of patients across multiple types of tumors, as presented in Table 1. This evidence concerns the gene PDS5B and neoplasm.